KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.24 $1.68 Friday, 26th Apr 2024 IFRX stock ended at $1.33. This is 4.32% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 11.64% from a day low at $1.28 to a day high of $1.43.
90 days $1.24 $1.92
52 weeks $1.14 $5.20

Historical InflaRx N.V. prices

Date Open High Low Close Volume
Apr 26, 2024 $1.41 $1.43 $1.28 $1.33 169 301
Apr 25, 2024 $1.36 $1.41 $1.26 $1.39 146 050
Apr 24, 2024 $1.37 $1.43 $1.33 $1.36 71 453
Apr 23, 2024 $1.39 $1.45 $1.32 $1.36 97 130
Apr 22, 2024 $1.35 $1.41 $1.31 $1.37 115 748
Apr 19, 2024 $1.27 $1.38 $1.27 $1.35 136 068
Apr 18, 2024 $1.26 $1.42 $1.25 $1.26 119 920
Apr 17, 2024 $1.33 $1.34 $1.24 $1.27 274 058
Apr 16, 2024 $1.38 $1.40 $1.25 $1.31 177 954
Apr 15, 2024 $1.50 $1.50 $1.37 $1.39 145 820
Apr 12, 2024 $1.54 $1.55 $1.45 $1.50 223 218
Apr 11, 2024 $1.60 $1.65 $1.51 $1.54 114 627
Apr 10, 2024 $1.54 $1.66 $1.51 $1.52 932 269
Apr 09, 2024 $1.53 $1.66 $1.46 $1.62 453 170
Apr 08, 2024 $1.59 $1.64 $1.51 $1.52 80 289
Apr 05, 2024 $1.56 $1.68 $1.50 $1.55 364 003
Apr 04, 2024 $1.55 $1.59 $1.50 $1.56 140 064
Apr 03, 2024 $1.54 $1.66 $1.52 $1.55 221 929
Apr 02, 2024 $1.55 $1.58 $1.51 $1.54 56 311
Apr 01, 2024 $1.55 $1.59 $1.51 $1.52 49 940
Mar 28, 2024 $1.57 $1.57 $1.51 $1.54 316 758
Mar 27, 2024 $1.52 $1.60 $1.52 $1.54 189 797
Mar 26, 2024 $1.54 $1.60 $1.52 $1.54 95 935
Mar 25, 2024 $1.50 $1.61 $1.50 $1.54 146 843
Mar 22, 2024 $1.53 $1.59 $1.49 $1.49 396 480
Click to get the best stock tips daily for free!

About InflaRx N.V.

InflaRx N.V. InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III c... IFRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT